The Imagion Biosystems Annual Report for the year ended 31 December 2018 is available here. Download the 2018 Annual Report.
Annual Report to Shareholders
Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.